Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2021
Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5Julie V Selkirk, Kevin C Dines, Yingzhuo Grace Yan, et al.
Antibodies (Basel, Switzerland)|August 22, 2023
Exploring Parametric and Mechanistic Differences between Expi293F<sup>TM</sup> and ExpiCHO-S<sup>TM</sup> Cells for Transient Antibody Production OptimizationJing Zhou, Guoying Grace Yan, David Cluckey, et al.
Plos One|April 3, 2020
Precursors to non-invasive clinical dengue screening: Multivariate signature analysis of in-vivo diffuse skin reflectance spectroscopy on febrile patients in MalaysiaAbdul Halim Poh, Faisal Rafiq Mahamd Adikan, Mahmoud Moghavvemi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 6, 2021
Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor ModulatorSekhar Surapaneni, Usha Yerramilli, April Bai, et al.
Journal of Medicinal Chemistry|January 23, 2009
Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR)Brenton Flatt, Richard Martin, Tie-Lin Wang, et al.
The FEBS Journal|August 12, 2009
Oligomerization is required for the activity of recombinant soluble LOX-1Wei Cao, Valerie Calabro, Adam Root, et al.
Bio-Protocol|June 17, 2026
In-Culture Antibody Capture Using Transient CHO Expression SystemsJing Zhou, Lauren Gebhardt, Molica Abel, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2014
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβEllen Kick, Richard Martin, Yinong Xie, et al.
Antibodies (Basel, Switzerland)|October 25, 2024
Metabolic Engineering of Glycofusion Bispecific Antibodies for α-DystroglycanopathiesXiaotian Zhong, Guoying Grace Yan, Apurva Chaturvedi, et al.
Antibodies (Basel, Switzerland)|October 24, 2025
A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform TechnologyLauren Gebhardt, Molica Abel, Jing Zhou, et al.
Pageof 3